Senior Member Spanker Posted November 12, 2013 Senior Member Share Posted November 12, 2013 So, I finally made it to the replicel website and I checked out the phase 1 photo and the stats, and actually, it did look pretty good (about like someone who responded well to minox or had a decent response to fin). There is still much that is unknown, like, how long will a person who experiences gains keep them? I think it said that there was about an 11 percent jump in hair count on average, up to 19 percent, which would be fantastic for many people. The caliber of the hair was increased as well adding to hair mass. I wonder if there was a post injection shed? Apparently, early this coming year they are applying to the German version of the FDA to go into phase 2, so it will be interesting to see when that takes place. So, since I am a busy guy instead of doing a lot of research, I took a look at their stock, because I figured that is a good way to tell what direction a company is headed. I have to say, it is headed in the wrong direction. I looked at a 3 year chart and there was a pretty sharp drop after it went on the market, followed by a pretty steady decline, followed by it basically leveling off. I hope there is something to this eventually, at least as an adjunct to other treatments. Any thoughts on this? I am an online representative for Dr. Raymond Konior who is an elite member of the Coalition of Independent Hair Restoration Physicians. View Dr. Konior's Website View Spanker's Website I am not a medical professional and my opinions should not be taken as medical advice. Link to comment Share on other sites More sharing options...
Senior Member Blake Bloxham Posted November 12, 2013 Senior Member Share Posted November 12, 2013 Hey Spanker, Replicel's fate, in my opinion, is still a bit unknown. They were recently infused with about $ 4 million from a Japanese company, so it will be interesting to see where that goes. However, I've heard others make similar comments about the stock. It will be interesting to see how both Replicel and Histogen progress into phase II clinical trails. "Doc" Blake Bloxham - formerly "Future_HT_Doc" Forum Co-Moderator and Editorial Assistant for the Hair Transplant Network, the Hair Loss Learning Center, the Hair Loss Q&A Blog, and the Hair Restoration Forum All opinions are my own and my advice does not constitute as medical advice. All medical questions and concerns should be addressed by a personal physician. Link to comment Share on other sites More sharing options...
Regular Member crafter Posted November 13, 2013 Regular Member Share Posted November 13, 2013 Hey Spanker, Replicel's fate, in my opinion, is still a bit unknown. They were recently infused with about $ 4 million from a Japanese company, so it will be interesting to see where that goes. However, I've heard others make similar comments about the stock. It will be interesting to see how both Replicel and Histogen progress into phase II clinical trails. this doesn't sound too good...hope they don't go the same way as Aderans :-/ Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now